European Journal of Medicinal Chemistry 2010-09-01

Cytotoxicity against cholangiocarcinoma cell lines of zerumbone derivatives.

Uraiwan Songsiang, Siripit Pitchuanchom, Chantana Boonyarat, Chariya Hahnvajanawong, Chavi Yenjai

Index: Eur. J. Med. Chem. 45 , 3794-802, (2010)

Full Text: HTML

Abstract

Cholangiocarcinoma (CCA) is an aggressive malignancy with a very high morbidity and mortality for which an effective treatment is lacking. In this study, seventeen zerumbone derivatives were synthesized and evaluated for in vitro cytotoxicity against cholangiocarcinoma cell lines. 5 showed the most potent antiproliferative activity against KKU-100 cell line with an IC(50) value of 16.44 microM. To investigate the potential molecular target of the most active compound, the docking was performed using different enzymes and receptor proteins including CDK-2, CDK-5, EGFR, and GSK-3. The docking results revealed that 5 exhibited better binding interaction to EGFR than CDK-2, CDK-5 and GSK-3. All results indicate that 5 should be a promising candidate for treatment of cancer.2010 Elsevier Masson SAS. All rights reserved.


Related Compounds

  • zerumbone

Related Articles:

Zingiber zerumbet CYP71BA1 catalyzes the conversion of α-humulene to 8-hydroxy-α-humulene in zerumbone biosynthesis.

2011-03-01

[Cell. Mol. Life Sci. 68(6) , 1033-40, (2011)]

Altered cross-linking of HSP27 by zerumbone as a novel strategy for overcoming HSP27-mediated radioresistance.

2011-03-15

[Int. J. Radiat. Oncol. Biol. Phys. 79(4) , 1196-205, (2011)]

Effects of selected food phytochemicals in reducing the toxic actions of TCDD and p,p'-DDT in U937 macrophages.

2010-12-01

[Arch. Toxicol. 84(12) , 957-66, (2010)]

Ginger phytochemicals mitigate the obesogenic effects of a high-fat diet in mice: a proteomic and biomarker network analysis.

2011-09-01

[Mol. Nutr. Food. Res. 55 Suppl 2 , S203-13, (2011)]

Anti-inflammatory effect of zerumbone on acute and chronic inflammation models in mice.

2010-10-01

[Fitoterapia 81(7) , 855-8, (2010)]

More Articles...